AERI - Aerie Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.04B
Enterprise Value 3
903.05M
Trailing P/E
N/A
Forward P/E 1
-9.70
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
17.46
Price/Book (mrq)
4.95
Enterprise Value/Revenue 3
15.13
Enterprise Value/EBITDA 6
-5.03

Trading Information

Stock Price History

Beta (5Y Monthly) 0.45
52-Week Change 3-40.45%
S&P500 52-Week Change 324.46%
52 Week High 350.10
52 Week Low 317.15
50-Day Moving Average 320.19
200-Day Moving Average 323.60

Share Statistics

Avg Vol (3 month) 31.2M
Avg Vol (10 day) 3802.02k
Shares Outstanding 546.32M
Float 35.31M
% Held by Insiders 11.84%
% Held by Institutions 1112.53%
Shares Short (Nov 29, 2019) 414.74M
Short Ratio (Nov 29, 2019) 412.72
Short % of Float (Nov 29, 2019) 437.89%
Short % of Shares Outstanding (Nov 29, 2019) 431.82%
Shares Short (prior month Oct 31, 2019) 414.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-317.45%

Management Effectiveness

Return on Assets (ttm)-30.04%
Return on Equity (ttm)-82.04%

Income Statement

Revenue (ttm)59.69M
Revenue Per Share (ttm)1.32
Quarterly Revenue Growth (yoy)154.00%
Gross Profit (ttm)-3M
EBITDA -179.66M
Net Income Avi to Common (ttm)-195.98M
Diluted EPS (ttm)-4.32
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)340.78M
Total Cash Per Share (mrq)7.36
Total Debt (mrq)201.59M
Total Debt/Equity (mrq)96.36
Current Ratio (mrq)5.43
Book Value Per Share (mrq)4.55

Cash Flow Statement

Operating Cash Flow (ttm)-154.82M
Levered Free Cash Flow (ttm)-92.14M